MAPK8 and hepatocellular carcinoma: The miR-125a-5p attenuates the activation of the JNK signaling pathway by targeting protein tyrosine phosphatase N1 (PTPN1) and MAP3K11, thus preventing the growth of HCC cells and inducing apoptosis.